SBIR-STTR Award

IGF::OT::IGF Aerosolized Delivery of Anti-Tubercular Drugs
Award last edited on: 5/7/14

Sponsored Program
SBIR
Awarding Agency
NIH : NIAID
Total Award Amount
$224,916
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Ronnie Toddywala

Company Information

Nostrum Pharmaceuticals LLC (AKA: Nostrum Technologies Llc)

1370 Hamilton Street
Somerset, NJ 08873
   (732) 543-2440
   info@nostrumpharma.com
   www.nostrumpharma.com
Location: Single
Congr. District: 12
County: Somerset

Phase I

Contract Number: 272201300013C-0-0-1
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2013
Phase I Amount
$224,916
Develop an inexpensive, easy to use, aerosolized delivery system of a combination of anti-tubercular drugs that could be used for the treatment of multi-drug resistant tuberculosis (MDR TB ).

NIH Spending Category:
Antimicrobial Resistance; Emerging Infectious Diseases; HIV/AIDS; Infectious Diseases; Orphan Drug; Rare Diseases; Tuberculosis

Project Terms:
aerosolized; drug efficacy; Drug Formulations; Drug Kinetics; Multidrug-Resistant Tuberculosis; Pharmaceutical Preparations; System; Testing; Toxic effect

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----